Guest guest Posted August 27, 2011 Report Share Posted August 27, 2011 BlankMutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B-cells. F Ghiotto, P Marcatili, C Tenca, MG Calevo, XJ Yan, E Albesiano, D Bagnara, M Colombo, G Cutrona, CC Chu, F Morabito, S Bruno, M Ferrarini, A Tramontano, F Fais, and N Chiorazzi Mol Med, July 13, 2011; Department of Experimental Medicine, University of Genoa, Genoa, Italy. B-cell chronic lymphocytic leukemia (CLL) patients display leukemic clones bearing either germline or somatically mutated IGHV genes. Most information on CLL Igs, such as the definition of stereotyped BCRs, was derived from germline unmutated Igs. In particular, detailed studies on the distribution and nature of mutations in paired heavy and light chain domains of CLL clones bearing mutated Igs are lacking. To address the somatic hypermutation dynamics of CLL Igs, we analyzed the mutation pattern of paired IGHV-D-J and IGK/LV-J rearrangements of 193 leukemic clones that displayed ? 2% mutations in at least one of the two IGVs (IGHV and/or IGK/LV). The relationship between the mutation frequency in IGHV and IGK/LV CDRs and FRs was evaluated by correlation analysis. Replacement ® mutation frequency within IGK/LV chain CDRs correlated significantly with mutation frequency of paired IGHV CDRs in lambda but not kappa isotype CLL clones. CDRs of IGKV-J rearrangements displayed a lower percentage of R mutations than IGHVs. The frequency/pattern of mutations in kappa CLL Igs differed also from that in kappa-expressing normal B cells described in literature. Instead, the mutation frequency within the FRs of IGHV and either IGKV or IGLV correlated. Notably, the amount of diversity introduced by replaced amino acids was comparable between IGHVs and IGKVs. The data indicate a different mutation pattern between kappa and lambda isotype CLL clones and suggest an antigenic selection that, in kappa samples, operates against CDR variation, PMID: 21785810 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.